Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Research Article Volume 4 Issue 4

Changes in the Behavior Pattern of Female Capuchin Monkeys After Chronic Administration of Hormonal Contraceptives

Rosângela Correa Rodrigues Duarte1*, Mosar Correa Rodrigues2, Taina de Abreu3, Tales Alexandre Aversi-Ferreira4 and Maria Clotilde Henriques Tavares1

1Department of Biology, State University of Feira de Santana (UEFS), Feira de Santana, Ba, Brazil
2Institute of Biology, University of Brasília (UnB), Brasilia- DF, Brazil
3Museum of Morphology, Federal University of Tocantins (UFT), Palmas-TO, Brazil
4Laboratory of Environmental Biotechnology and Genotoxicity Plant Biotechnology, Institute of Nature Sciences, Federal University of Alfenas, Alfenas-MG, Brazil
5Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brailia, FederalDistrict, Brazil

*Corresponding Author: Rosângela Correa Rodrigues Duarte, Department of Biology, State University of Feira de Santana (UEFS), Feira de Santana-Ba, Brazil.

Received: October 08, 2021; Published: March 10, 2022


The benefits of hormonal contraceptives are undeniable; however, these drugs are also related to numerous adverse and side effects, especially physiological parameters. Although there are several reports of changes in behavioral patterns, there are controversies about the impact of hormonal contraceptives on these aspects. Therefore, this issue needs to be investigated how changes in users' behavior affect their self-esteem and quality of life. Furthermore, there is a need for studies that relate the effect of contraceptives on the expression of behaviors, as few animal models seek to elucidate these effects. In this sense, this study aimed to evaluate the behavioral aspects of female monkeys after the administration of hormonal contraceptives. For this, six adult female monkeys were used. This study received five administrations of kelp acetophenide and estradiol enanthate, a combined hormonal contraceptive substance. The females received a dose of 0.10ml every 21 days, i.e., once every menstrual cycle. Behavioral aspects were monitored daily before, during, and after the administration of the hormonal contraceptive. In addition, the frequency of sexual behavior and the duration of non-sexual behavior were observed. For this purpose, each female was observed for 20 minutes continuously for five cycles, all experiment phases. Thus, it was observed that administrations of the algal acetophenone and estradiol enanthate composition promoted a decline in the frequency of sexual behavior in female capuchin monkeys. Finally, it is necessary to report that in addition to the adverse effects on the behavior of users, contraceptives bring collection effects to physiological aspects, which can be severe. Thus, it is necessary to have wide dissemination of these adverse and side effects because women need to know about such physiological and behavioral impairments, which can be severe for their health.

Keywords:Behaviour; Monkeys; Contraceptive Hormone; Sexual


  1. Chandra A., et al. “Fertility, family planning, and reproductive health of U. S. women”. National Center for Health Statistic 3 (2005): 89-95.
  2. Margolis K., et al. “A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women”. Fertility and Sterility 2 (2007): 310-316.
  3. Blumenthal PD and Edelman A. “Hormonal contraception”. Obstetric Gynecology 3 (2008): 670-684.
  4. Coutinho EM., et al. “Multicenter, doubleblind, comparative clinical study on the efficacy and acceptability of a monthly injectable contraceptive combination of 150 mg dihydroxyprogesterone acetophenide and 10 mg estradiol enanthate compared to a monthly injectable contraceptive combination of 90 mg dihydroxyprogesterone acetophenide and 6 mg estradiol enanthate”. Contraception 2 (1997): 175-181.
  5. Vlieg AH and Rosendaal FR. “Risk of venous thrombosis associated with different types of combined oral contraceptive preparations”. Polish Archives of Internal Medicine 11 (2014): 85-87.
  6. Hall KS., et al. “Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women”. Contraception 5 (2012): 518-525.
  7. Xu H., et al. “Contraceptive Failure Rates of Etonogestrel Subdermal Implants in Overweight and Obese Women”. Obstetrics and Gynecology1 (2012): 21-26.
  8. Lanza LL., et al. “Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture”. Obstetrics and Gynecology3 (2013): 593-600.
  9. Wanyonyi SZ., et al. “Health‐related quality of life changes among users of depot medroxyprogesterone acetate for contraception”. Contraception5 (2011): 17-22.
  10. Roberts SC., et al. “An Evolutionary Approach Offers a Fresh Perspective on the Relationship Between Oral Contraception and Sexual Desire”. Archives of Sexual Behavior8 (2013): 1369-1375.
  11. Davis SR., et al. “Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine”. The Journal of Sexual Medicine8 (2016): 168-178.
  12. Zimmerman MJC., et al. “The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis”. Humuns Reproduction Update1 (2014): 76-105.
  13. Strufaldi R., et al. “Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels”. Contraception 2 (2010): 147-154.
  14. Rodrigues RC., et al. “Risco de doença trombolíticas Após o uso de algestona acetofenida e enantato de estradiol”. Revista de Patologia1 (2018): 17-21.
  15. Rodrigues RC., et al. “Continuous Use of Combined Hormonal Contraceptive and the Effect on Blood Coagulation Factors in Female Capuchin Monkeys (Sapajus libidinosus)”. International Journal of Endocrinology (2019).
  16. Strier KB. “Reproductive strategies of new world primates: interbirth intervals and reproductive rates”. A Primatologia no Brasil1 (2004): 53-63.
  17. Jack KM., et al. “Hormonal correlates of male life history stages in wild white-faced capuchin monkeys (Cebus capucinus)”. General and Comparative Endocrinology1 (2004): 58-67.
  18. Carosi M., et al. “The Sexual Behavior and Breeding System of Tufted Capuchin Monkeys (Cebus apela)”. Advances in the Study of Behavior5 (2005): 105-149.
  19. Aujard F., et al. “Functional significance of behavioral, morphological, and endocrine correlates across the ovarian cycle in semifree ranging female Tonkean macaques”. American Journal of Primatology4 (1998): 285-309.
  20. Lima MC., et al. “Monitoring in plasma sanguineous sex steroids during the cycle ovarian Sapajus apella and Sapajus libidinosus (capuchin monkey) kept in captivity”. Ciência Animal5 (2012): 65-67.
  21. Fragaszy DM., et al. “Wild Bearded Capuchin Monkeys (Sapajus libidinosus) Strategically Place Nuts in a Stable Position during Nut-Cracking”. Plos One2 (2005): 56182.
  22. Pachaly JR and Brito HFV. “Emprego do método de extrapolação alométrica no cálculo de protocolos posológicos para animais selvagens”. A Hora Veterinaria1 (2000). 59-65.
  23. Altmann J. “Observational study of behavior: sampling methods”. University of Chicago. 1 (1979): 242-247.
  24. Martin P and Bateson P. “Measuring behaviour”. Cambridge: Cambridge University Press. 2 (1993): 48-60.
  25. Alexander GM and Sherwin BB. “Sex steroids, sexual behavior and selection attention for erotic stimuli in women using oral contraceptives”. Psychoneuroendocrinology 2 (1993): 91-102.
  26. Baumeister R. “Sexual economics: sex as female resource for social exchange in heterosexual interactions”. Personality and Social Psychology Review4 (2004): 339-363.
  27. Van Anders SM., et al. “Effects of gendered behavior on testosterone in women and men”. PNAS 45 (2015): 13805-13810.
  28. Fooladi E., et al. “Testosterone Improves Antidepressant-Emergent Loss of Libido in Women: Findings from a Randomized, Double-Blind, Placebo-Controlled Trial”. Journal Sexual Medicine3 (2014): 831-839.
  29. Wallwiener CW., et al. “Prevalence of Sexual Dysfunction and Impact of Contraception in Female German Medical Students”. The Journal of Sexual Medicine6 (2010): 2139-2148.
  30. Denson TF., et al. “Self-Control and Aggression”. Current Directions in Psychological Science1 (2012): 20-25.
  31. Boisseau N., et al. “Oral contraception but not menstrual cycle phase is associated with increased free cortisol levels and low hypothalamo-pituitary-adrenal axis reactivity”. Journal of Endocrinological Investigation 1 (2013): 955-964.
  32. Okoth K., et al. “Association between the reproductive health of young women and cardiovascular disease in later life: umbrella revie”. BMJ 371 (2020): m3502.
  33. Ashraf M., et al. “Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity”. Blood Coagulation Fibrinolysis3 (2012): 203-207.
  34. Dragoman MV. “The combined oral contraceptive pill- recente developments, risks and benefits”. Clinical Obstetrics and Gynecology6 (2014): 1-10.
  35. Khialani D., et al. “Hormonal Contraceptives and the Risk of Venous Thrombosis”. Seminars in Thrombosis and Hemostasis08 (2020): 865-871.
  36. Monroe DM and Hoffman M. “Theories of Blood Coagulation: Basic Concepts and Recent Updates”. Duke University, Durham. 1 (2012).
  37. Sandset PM., et al. “Mechanisms of thrombosis related to hormone therapy”. Thrombosis Research2 (2009): 70-73.
  38. Lidegaard O., et al. “Thrombotic stroke and myocardial infarction with hormonal contraception”. The New England Journal Medicine24: (2012) 2257-2266.
  39. Manzoli L., et al. “Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis”. Drug Safety3 (2012): 191-205.


Citation: Rosângela Correa Rodrigues Duarte., et al. “Changes in the Behavior Pattern of Female Capuchin Monkeys After Chronic Administration of Hormonal Contraceptives". Acta Scientific Women's Health 4.4 (2022): 02-08.


Copyright: © 2022 Rosângela Correa Rodrigues Duarte., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US